Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 036360 Name of the Signatory :- K. Hanumantha RaoDesignation :- Company Secretary and Compliance Officer Shareholding for the Period Ended June 30, 2018
Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences secures Product Patents in Europe and South Korea Suven Life gets product patents from India, Singapore, South Korea, Israel
These patents are valid through 2031, 2034, 2034 and 2036 respectively, the company said in a BSE filing Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences secures Product Patents in India, Singapore,South Korea and Israel Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement regarding reminder to claim the dividends remaining unpaid/ unclaimed and transfer of unclaimed equity shares of the Company to the Investor Education and Protection Fund (IEPF) Suspense Account Suven Life gets product patents from China, US
Suven Life Sciences today said it has been granted a product patent by China and the US each for a new chemical entity (NCE) for treatment of disord Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences secures Product Patents in China and USA Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences is participating and presenting in 'Jefferies Global Healthcare Conference', New York on June 8, 2018 Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences participating at Sleep 2018 at Baltimore, MD. USA.